LeMaitre Vascular, Inc. (NASDAQ:LMAT) has scheduled a conference call for 29th October 2020 at 5:00 PM Eastern Time to announce its 3Q20 financial results.
The conference call will also be webcast live under the investor relations section of the website www.lemaitre.com
Earnings Expectation
LeMaitre Vascular, Inc. is set to announce third quarter earning results on Thursday 29th October 2020, after market close.
Analysts surveyed by Thomson Reuters are predicting, LMAT to report 3Q20 income of $ 0.19 per share. For the full year, analysts anticipate top line of $ 120.47 million, while looking forward to income of $ 0.74 per share bottom line.
The Company Outlook
Earnings for 3Q20 are anticipated in a range of $ 0.17 ~ $ 0.26 per share, while revenues are expected in a range of $ 30.50 million ~ $ 34.50 million
Full Year 2020 topline are forecasted in a range of$ 127.40 million ~ $ 130.80 million, where as bottomline are predicted in a range of $ 0.90 ~ $ 0.98 per share
Click Here For More Historical Outlooks Of LeMaitre Vascular, Inc.
LeMaitre Vascular, Inc. designs, markets, sells, services, and supports medical devices and implants for the treatment of peripheral vascular disease worldwide. The company offers angioscope, a fiber optic catheter used for viewing the lumen of a blood vessel; embolectomy catheters to remove blood clots from arteries or veins; occlusion catheters that temporarily occlude the blood flow; perfusion catheters to temporarily perfuse the blood and other fluids into the vasculature; and thrombectomy catheters, which features a silicone balloon for removing thrombi in the venous system.
